Yifan Xinfu Pharmaceutical Co Ltd (002019) — Free Cash Flow Generation Index
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Free Cash Flow Generation Index of -3.60x as of September 2025. Free cash flow of CN¥-144.50 Million represents -4% of operating cash flow (CN¥40.18 Million). See how liquid is Yifan Xinfu Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 21 annual periods. Explore Yifan Xinfu Pharmaceutical Co Ltd (002019) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Yifan Xinfu Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002019 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | CN¥-100.87 Million | CN¥458.37 Million | CN¥559.23 Million | ▼ -1221.3% |
| 2024 | 0.02x | CN¥12.57 Million | CN¥640.73 Million | CN¥628.16 Million | ▲ +104.4% |
| 2023 | -0.45x | CN¥-155.50 Million | CN¥348.58 Million | CN¥504.09 Million | ▼ -199.9% |
| 2022 | -0.15x | CN¥-70.21 Million | CN¥472.07 Million | CN¥542.27 Million | ▲ +83.4% |
| 2021 | -0.90x | CN¥-270.51 Million | CN¥301.23 Million | CN¥571.74 Million | ▼ -353.4% |
| 2020 | 0.35x | CN¥392.80 Million | CN¥1.11 Billion | CN¥715.71 Million | ▲ +366.7% |
| 2019 | 0.08x | CN¥71.17 Million | CN¥937.24 Million | CN¥866.07 Million | ▼ -79.9% |
| 2018 | 0.38x | CN¥441.69 Million | CN¥1.17 Billion | CN¥729.21 Million | ▼ -33.9% |
| 2017 | 0.57x | CN¥646.87 Million | CN¥1.13 Billion | CN¥485.86 Million | ▼ -14.0% |
| 2016 | 0.66x | CN¥568.34 Million | CN¥855.85 Million | CN¥287.50 Million | ▲ +44.4% |
| 2015 | 0.46x | CN¥184.81 Million | CN¥401.96 Million | CN¥217.15 Million | ▲ +27.9% |
| 2014 | 0.36x | CN¥50.23 Million | CN¥139.74 Million | CN¥89.51 Million | ▼ -56.1% |
| 2013 | 0.82x | CN¥28.10 Million | CN¥34.32 Million | CN¥73.95 Million | ▲ +164.8% |
| 2012 | -1.26x | CN¥-37.76 Million | CN¥29.88 Million | CN¥67.64 Million | ▲ +20.1% |
| 2009 | -1.58x | CN¥-92.66 Million | CN¥58.61 Million | CN¥151.27 Million | ▼ -236.4% |
| 2008 | -0.47x | CN¥-39.15 Million | CN¥83.31 Million | CN¥122.46 Million | ▼ -252.5% |
| 2007 | 0.31x | CN¥76.64 Million | CN¥248.71 Million | CN¥172.06 Million | ▲ +140.2% |
| 2006 | -0.77x | CN¥-25.01 Million | CN¥32.62 Million | CN¥57.62 Million | ▲ +46.4% |
| 2005 | -1.43x | CN¥-34.51 Million | CN¥24.12 Million | CN¥58.63 Million | ▼ -31.5% |
| 2004 | -1.09x | CN¥-36.55 Million | CN¥33.59 Million | CN¥70.14 Million | ▲ +65.4% |
| 2003 | -3.14x | CN¥-39.78 Million | CN¥12.65 Million | CN¥52.44 Million | — |